Mucovim (Acetylcysteine)

Acetylcysteine, the active ingredient in Mucovim, is a mucolytic presented as an oral dosage form for oral use. It reduces mucus viscosity and facilitates clearance in respiratory conditions such as chronic bronchitis, COPD, and asthma.

GNH USA supplies Mucovim as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Acetylcysteine acts on the respiratory mucus pathway to improve airway clearance.

- Chronic bronchitis: helps thin mucus, making it easier to expectorate. - Chronic obstructive pulmonary disease (COPD): reduces sputum viscosity and supports breathing. - Asthma: assists in clearing mucus plugs during exacerbations.

Acetylcysteine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools occurring after oral intake. - Taste disturbance: a sulfur-like or unpleasant taste. - Abdominal discomfort: cramping or mild pain. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Bronchospasm: sudden narrowing of the airways, especially in asthmatic patients. - Anaphylaxis: severe allergic reaction with hives, swelling, and difficulty breathing. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Hemolysis in G6PD deficiency: rapid breakdown of red blood cells.

When using Acetylcysteine, consider the following safety measures.

- Assess renal function: adjust use in patients with severe kidney impairment. - Monitor for bronchospasm: especially in individuals with active asthma. - Use with caution in pregnancy: limited data, weigh benefits against risks. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Adjust dose in hepatic impairment: liver disease may affect metabolism. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Acetylcysteine can affect the activity of several medicines.

Major Interactions (Avoid): - Nitroglycerin: may enhance hypotensive effects. - Activated charcoal: reduces oral absorption of acetylcysteine. - Warfarin: potential increase in INR and bleeding risk.

Moderate Interactions (Monitor Closely): - Bronchodilators (e.g., albuterol): may experience altered response. - Anticholinergic agents: possible additive effects on airway secretions. - Other mucolytics: increased risk of gastrointestinal irritation. - Oral contraceptives: may slightly reduce efficacy.